DJIA 18,033.00 -37.40 -0.21%
NASDAQ 4,968.45 -48.48 -0.97%
S&P 500 2,102.32 -12.17 -0.58%
market minute promo

467.38 -6.79 (-1.43%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $467.38 -1.43%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $472.16
Previous Close $474.17
Daily Range $462.29 - $473.10
52-Week Range $269.50 - $495.50
Market Cap $48.0B
P/E Ratio 154.45
Dividend (Yield) $0.00 (0.0%)
Volume 165,070
Average Daily Volume 800,840
Current FY EPS $7.79

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary

Express Scripts Issues Upbeat Outlook Despite Shifting Competitive Landscape

As UnitedHealth gobbles up Catamaran, Express Scripts is now swimming with the sharks, so why isn't the PBM market leader flinching?

Beyond Pharma: 3 Healthcare Choices - Analyst Blog

pSivida, Moore's Law, Pfizer, And The Next Regeneron

Cramer -- Yelp Suffers as Business Slows; Celgene Earnings Disappoint

Amgen Ticks All The Boxes For A Perfect Investment

Regeneron Bounces Higher Off Support

The 3 Best Stocks for Investing in Cholesterol Drugs

An aging population and rising prevalence of heart disease suggest that investing in the next generation of cholesterol drugs could prove to be profitable.

3 Potential Blockbuster Drugs That Could Be Approved Before Year's End

Our experts weigh in on some drug candidates with huge potential.

10 Largest Companies by Market Cap in Biotech

The bigger they are, the harder they climb? How the biggest biotechs are booming.

Jim Cramer -- If You're Not in Biotech for the Long Haul, Hit the Road

See More REGN News...

REGN's Top Competitors

REGN $467.38 (-1.43%)
Current stock: REGN
AMGN $160.27 (-1.14%)
Current stock: AMGN
GILD $103.49 (-2.05%)
Current stock: GILD
BIIB $384.25 (-0.51%)
Current stock: BIIB